CDK2 and neoplasm: Overexpression of cyclin E was previously reported as a mechanism to evade CDK4/6 inhibition because it can activate CDK2 and Rb phosphorylation to re-enter the cell cycle, as observed in preclinical studies18,19,32,33 and retrospective analyses of tumor tissues34,35.